3/26
05:49 am
prax
Praxis Precision Medicines (PRAX) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
Praxis Precision Medicines (PRAX) was upgraded by Truist Financial Corporation to "strong-buy".
3/18
02:00 pm
prax
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit [Yahoo! Finance]
Low
Report
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit [Yahoo! Finance]
3/18
03:28 am
prax
Will Extended Cash Runway And Dual FDA Filings Shift Praxis Precision Medicines' (PRAX) Narrative Toward Commercialization? [Yahoo! Finance]
Medium
Report
Will Extended Cash Runway And Dual FDA Filings Shift Praxis Precision Medicines' (PRAX) Narrative Toward Commercialization? [Yahoo! Finance]
3/16
06:50 pm
prax
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter [Yahoo! Finance]
Low
Report
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter [Yahoo! Finance]
3/15
08:22 am
prax
Is Praxis Precision Medicines (PRAX) Still Attractive After Its Big Share Price Run? [Yahoo! Finance]
Medium
Report
Is Praxis Precision Medicines (PRAX) Still Attractive After Its Big Share Price Run? [Yahoo! Finance]
3/14
01:26 pm
prax
Praxis FDA Filings Shift Focus From Pipeline Promise To Potential Revenue [Yahoo! Finance]
Medium
Report
Praxis FDA Filings Shift Focus From Pipeline Promise To Potential Revenue [Yahoo! Finance]
3/13
10:44 am
prax
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline [Yahoo! Finance]
Medium
Report
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline [Yahoo! Finance]
3/13
09:54 am
prax
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings [Yahoo! Finance]
Medium
Report
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings [Yahoo! Finance]
3/9
11:05 am
prax
Praxis Precision Medicines (PRAX) had its "buy" rating reaffirmed by BTIG Research.
Low
Report
Praxis Precision Medicines (PRAX) had its "buy" rating reaffirmed by BTIG Research.
3/4
04:01 pm
prax
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/25
06:24 am
prax
Praxis Precision Medicines (PRAX) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Praxis Precision Medicines (PRAX) was upgraded by Wolfe Research to "strong-buy".
2/24
07:23 am
prax
A Look At Praxis Precision Medicines (PRAX) Valuation After Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Look At Praxis Precision Medicines (PRAX) Valuation After Recent Share Price Momentum [Yahoo! Finance]
2/23
06:01 pm
prax
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/20
10:33 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its price target raised by analysts at Truist Financial Corporation from $500.00 to $700.00. They now have a "buy" rating on the stock.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its price target raised by analysts at Truist Financial Corporation from $500.00 to $700.00. They now have a "buy" rating on the stock.
2/20
09:13 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) was given a new $433.00 price target on by analysts at Robert W. Baird.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) was given a new $433.00 price target on by analysts at Robert W. Baird.
2/20
08:28 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its price target raised by analysts at Wedbush from $95.00 to $130.00. They now have an "underperform" rating on the stock.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its price target raised by analysts at Wedbush from $95.00 to $130.00. They now have an "underperform" rating on the stock.
2/20
08:06 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
2/20
08:02 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) was given a new $305.00 price target on by analysts at Wells Fargo & Company.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) was given a new $305.00 price target on by analysts at Wells Fargo & Company.
2/19
02:15 pm
prax
Praxis Precision Medicines Inc (PRAX) Q4 2025 Earnings Call Highlights: Strong Financial ... [Yahoo! Finance]
Low
Report
Praxis Precision Medicines Inc (PRAX) Q4 2025 Earnings Call Highlights: Strong Financial ... [Yahoo! Finance]
2/19
12:45 pm
prax
Praxis Precision Medicines Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Praxis Precision Medicines Q4 Earnings Call Highlights [Yahoo! Finance]
2/19
07:30 am
prax
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Low
Report
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
2/19
03:53 am
prax
Praxis Precision Medicines, Inc. (PRAX) Gains Analyst Confidence With Ulixacaltamide [Yahoo! Finance]
Low
Report
Praxis Precision Medicines, Inc. (PRAX) Gains Analyst Confidence With Ulixacaltamide [Yahoo! Finance]
2/18
07:42 am
prax
Praxis Precision Medicines Inc (PRAX) Q4 2025 Earnings Report Preview: What To Look For [Yahoo! Finance]
Low
Report
Praxis Precision Medicines Inc (PRAX) Q4 2025 Earnings Report Preview: What To Look For [Yahoo! Finance]
2/16
12:38 pm
prax
Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX) [Yahoo! Finance]
Low
Report
Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX) [Yahoo! Finance]
2/13
07:02 pm
prax
Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800 [Yahoo! Finance]
Low
Report
Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800 [Yahoo! Finance]